Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
OHE at HESG: Value-based Assessment in the UK; Developing the EQ-5D-5L
23 January 2014
OHE’s contributions focused on approaches to implementing UK value-based assessment and the details of creating an EQ-5D-5L value set for England. The Health Economists’ Study Group…
Opportunity Costs of Implementing NICE Decisions in NHS Wales
1 June 2014
This new research from the OHE examines how Local Health Boards (LHBs) in Wales adjust spending to meet the statutory requirement of providing access to technologies…
Can the US Afford to Ignore Cost-effectiveness Evidence?
1 March 2014
Cost-effectiveness analysis plays a limited role in US health care compared to many other countries. In this Seminar Briefing, Dr James Chambers, Center for the Evaluation…
Projecting Expenditure on Medicines in the NHS: Second Edition
1 January 2014
The Pharmaceutical Price Regulation Scheme (PPRS) 2014 Heads of Agreement, announced on 6 November 2013, outlines the terms of the five-year deal between the pharmaceuctical industry…
Inconsistent Use of Cost-effectiveness Thresholds in NHS Scotland
12 December 2013
This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards. OHE today released a Research Paper on the…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
A pilot study demonstrated the value of involving a range of stakeholders in MCDA for rare disease therapies. According to a study just published by the…
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
This paper counters recent research that recommended NICE lower its threshold from the current official £20,000-£30,000. Critique of CHE Research Paper 81: Methods for the Estimation…
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for…
What Is the Role of Cost-Effectiveness Evidence in US Health Care?
31 July 2013
At an OHE seminar last week, Dr James Chambers of Tufts Medical School examined the role cost-effectiveness evidence plays in health care resource allocation in the…